October 07, 2026 11:27 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50% | ‘Completely false’: Virat Kohli reacts to ₹5 crore claim over Premanand Maharaj visit | We’re watching it very closely: US urges Russia to share more information on plague situation | This isn’t about schools: Trump blames ‘mass migration’ and Islam for violent protests across France | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘Vote thief’ Gyanesh Kumar: Rahul Gandhi climbs barricade, waves Tricolour during explosive INDIA bloc protest | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘He should not have been flying’: JD Vance on Flydubai co-pilot | Israel was ready to shoot down Flydubai jet if it kept flying towards Tel Aviv: Reports | 'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row

Banning Indian raw material can prove suicidal: Pakistan Pharmaceutical industry warns Imran govt

| @indiablooms | May 13, 2020, at 03:04 am

Islamabad/IBNS: Despite all their designs against India, Pakistan government is facing a dilemma. It is because of a plea from its own people against the banning of  Indian raw material for manufacturing drugs in the country, specially at this time when the nation is grappling with COVID-19 outbreak.

Pakistan depends heavily on Indian raw materials to manufacture drugs and if the government bans its import then that will lead to grievous situation in the country.

From 50 per cent loss in drug production to increase in its price,  such a move can prove to be deadly for Pakistan, warned representatives of the Pakistan Pharmaceutical Manufacturers’ Association.

PPMA senior vice chairman Syed Farooq Bukhari was quoted as saying by Dawn News during a press conference that the federal cabinet should not take any decision against the import of medicine raw material from India or from any other country when there had been an unabated increase in Covid-19 patients in the country.  

“At a time when the federal and provincial governments in the country have been in the process of setting up more and more quarantine centres, isolation facilities, and special hospital wards to accommodate Covid-19 cases, there is a dire need to ensure constant supply of essential medicines to treat coronavirus patients," Syed Farooq Bukhari said.

“For this, it is mandatory that the pharmaceutical industry of Pakistan should continue with its operations to its full capacity as for this we need a constant supply of raw material from our international clients,” he explained.

“Any decision to disrupt the international supply chains associated with the Pakistani pharmaceutical industry would negatively affect the ability of country’s medical practitioners to treat the cases of Covid-19,” he warned the government.

The situation highlighted how India is directly helping Pakistan even at this age of crisis and constant sponsoring of terrorism in Kashmir.

In reply to a question, former central chairmen of the PPMA Dr Kaiser Waheed was quoted as saying by Dawn News that 95 per cent of drugs were manufactured with the help of imported raw material in which Indian share was almost 50 pc while the rest was met by China and some European countries.

Very few medicines were imported in finished form from India which included vaccines, Waheed said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.